Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 15 (UBE2V1P15)
- Target
- UBE2V1P15
- Molecular classification
- Other (Pseudogene)
01
Overview
UBE2V1P15 is a pseudogene related to the UBE2V1 gene (Ubiquitin-conjugating enzyme E2 variant 1). Unlike the functional UBE2V1 gene, which encodes a protein involved in non-canonical polyubiquitination and cellular signaling pathways, UBE2V1P15 does not produce a functional protein and has no known biological function, disease association, or role as a drug target. Pseudogenes may occasionally be transcribed, but they do not have demonstrated protein-coding or functional activity.
- Other names
- UBE2V1 pseudogeneUBE2V1P
02
Mechanism of action
None; pseudogenes are non-coding and do not encode proteins or functional products targeted by drugs
03
Biological functions
None for the pseudogene itself, as it is non-functional
04
Disease associations
None directly linked to the pseudogene. Disease associations referenced for the functional UBE2V1 gene (not the pseudogene) include potential involvement in colon adenocarcinoma and other cellular processes, but not for UBE2V1P15.
Beyond the preview
Go deeper on Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 15 (UBE2V1P15).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 15 (UBE2V1P15).